AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $276,000 | +37.3% | 9,338 | +185.7% | 0.18% | +108.0% |
| Q3 2018 | $201,000 | -9.9% | 3,269 | -20.5% | 0.09% | +63.0% |
| Q1 2018 | $223,000 | -37.2% | 4,112 | -43.7% | 0.05% | -46.5% |
| Q3 2017 | $355,000 | -43.7% | 7,300 | -39.2% | 0.10% | -53.7% |
| Q2 2017 | $631,000 | +45.7% | 12,000 | +25.5% | 0.22% | +23.2% |
| Q1 2017 | $433,000 | +78.9% | 9,558 | +49.3% | 0.18% | +39.4% |
| Q4 2016 | $242,000 | – | 6,400 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |